000 01268 a2200361 4500
005 20250515162949.0
264 0 _c20090605
008 200906s 0 0 eng d
022 _a1538-3660
024 7 _a10.1001/archfacial.2009.5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMoy, Ronald
245 0 0 _aLong-term safety and efficacy of a new botulinum toxin type A in treating glabellar lines.
_h[electronic resource]
260 _bArchives of facial plastic surgery
_c
300 _a77-83 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 0 4 _aBotulinum Toxins, Type A
_xadverse effects
650 0 4 _aFace
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInjections
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeuromuscular Agents
_xadverse effects
650 0 4 _aSkin Aging
_xdrug effects
650 0 4 _aTreatment Outcome
650 0 4 _aUnited States
700 1 _aMaas, Corey
700 1 _aMonheit, Gary
700 1 _aHuber, M Barbara
773 0 _tArchives of facial plastic surgery
_gvol. 11
_gno. 2
_gp. 77-83
856 4 0 _uhttps://doi.org/10.1001/archfacial.2009.5
_zAvailable from publisher's website
999 _c18728546
_d18728546